Traumatic Facial Nerve Paralysis
Facial nerve injury due to temporal bone fracture, penetrating trauma, iatrogenic surgical injury, or birth trauma, presenting with weakness or complete paralysis of facial muscles, requiring urgent ENB and electrodiagnostic evaluation, with surgical decompression for severe cases (more than 90% degeneration on ENoG within 14 days).
This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.
This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →
What is Traumatic Facial Nerve Paralysis?
Traumatic facial nerve paralysis is the second most common cause of facial paralysis after idiopathic Bell palsy. Etiology categories: (1) Temporal bone fractures: longitudinal fractures (70-90% of all temporal bone fractures, parallel to long axis of petrous bone, usually from temporoparietal blows, facial nerve injury in 10-25% — typically perigeniculate or labyrinthine segment), transverse fractures (less common 10-30%, perpendicular to long axis, from frontal or occipital blows, facial nerve injury in 30-50% — at internal auditory canal or labyrinthine segment, often more severe), oblique/mixed fractures (most common in modern classification, intermediate severity). (2) Penetrating trauma: gunshot wounds, stab wounds, glass injuries to face or temporal area; injury can occur at any segment but extratemporal segment most accessible. (3) Iatrogenic injury: parotidectomy (most common surgical cause, 0.5-5% transient, less than 1% permanent), mastoidectomy/middle ear surgery (0.6-3.6%), acoustic neuroma resection, parotid bed surgery, mandibular surgery, facelift surgery. (4) Birth trauma: forceps delivery, prolonged labor, prematurity (peripheral facial weakness in newborn — usually transient).
Pathophysiology and Sunderland classification of nerve injury: (1) Neurapraxia (Sunderland I): conduction block without axonal injury, complete recovery within days to weeks. (2) Axonotmesis (Sunderland II-IV): axonal injury with intact endoneurium (II), perineurium (III), or epineurium (IV); Wallerian degeneration distal to injury, recovery via axonal regrowth (1 mm/day) with variable completeness. (3) Neurotmesis (Sunderland V): complete nerve transection, no spontaneous recovery, requires surgical repair. House-Brackmann grading clinically: I (normal), II (mild dysfunction), III (moderate, complete eye closure with effort), IV (moderately severe, incomplete eye closure), V (severe, barely perceptible motion), VI (total paralysis). Onset timing is critical prognostically: immediate complete paralysis suggests nerve transection or severe injury at impact (worse prognosis), while delayed-onset paralysis (within 24-72 hours) suggests progressive edema or hematoma compressing nerve in bony canal (better prognosis with conservative therapy or limited decompression).
Workup: high-resolution non-contrast temporal bone CT (1 mm slices) is the imaging modality of choice for all temporal bone trauma — identifies fracture patterns, otic capsule involvement (otic capsule-violating versus otic capsule-sparing classification, with violating fractures having higher rates of facial paralysis, hearing loss, and CSF leak), facial nerve canal involvement, ossicular discontinuity, and CSF leak. MRI for soft tissue visualization, suspected nerve hematoma, or atypical cases. Electrodiagnostic testing is critical for prognosis and surgical decision-making in immediate-onset complete paralysis: nerve excitability test (NET) and minimal nerve excitability test (MNET) early; electroneuronography (ENoG) is the gold standard between days 3-21 (compares amplitude of compound muscle action potential on injured side versus uninjured side — more than 90% degeneration within 14 days indicates surgical decompression); electromyography (EMG) after day 14-21 detects fibrillation potentials (denervation) versus volitional motor unit potentials (preserved or recovering function). Audiometry to document hearing status. Treatment: immediate-onset complete paralysis with more than 90% degeneration on ENoG within 14 days is the indication for surgical decompression — middle cranial fossa approach for labyrinthine and perigeniculate segments (most common injury location), transmastoid approach for tympanic and mastoid segments. Delayed-onset paralysis is treated with corticosteroids (prednisone 1 mg/kg/day for 7-10 days, then taper) and observation; recovery rate exceeds 90%. Penetrating injuries with transected nerve require immediate primary anastomosis (ideal) or cable nerve grafting with sural or great auricular nerve. Iatrogenic transection during surgery should be repaired immediately. Delayed reconstruction (more than 12 months) options: hypoglossal-facial nerve transfer (XII-VII), masseteric-facial nerve transfer (V-VII), cross-facial nerve grafting; static slings (temporalis transfer, fascia lata, palmaris longus) and dynamic procedures (gracilis free flap with masseteric or cross-facial neurotization) for long-standing complete paralysis. Adjunctive measures: artificial tears, taping eye closed at night, lateral tarsorrhaphy, gold weight implant, lower lid procedures for paralytic ectropion.
Symptoms
Risk Factors
When to See a Doctor?
If you experience any of the following symptoms, seek medical attention promptly:
- Acute facial weakness or paralysis after head trauma
- Facial weakness developing after surgery
- Newborn with asymmetric facial movement after difficult delivery
- Inability to close eye after trauma (corneal protection emergency)
- Hearing loss, ear bleeding, or CSF leak after head injury
- Progressive worsening of facial paralysis (compressive hematoma)
- Delayed facial weakness days after temporal bone trauma
Treatment Methods
Which Department to Visit?
You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.
Learn About KBB (Kulak Burun Boğaz) DepartmentLet us help you
You can make an appointment with our specialists or contact us for your concerns.
Related Health Topics
Other articles from the same department you may want to explore.
Anaemia
Dahiliye (İç Hastalıkları)
Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.
Iron Deficiency Anaemia
Dahiliye (İç Hastalıkları)
Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.
Vitamin B12 Deficiency
Dahiliye (İç Hastalıkları)
Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.
Hypertension (High Blood Pressure) Management
Dahiliye (İç Hastalıkları)
Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.
Chronic Kidney Disease
Dahiliye (İç Hastalıkları)
Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.
Hepatitis B (HBV)
Dahiliye (İç Hastalıkları)
Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.
Hepatitis C (HCV)
Dahiliye (İç Hastalıkları)
Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.
Fatty Liver Disease
Dahiliye (İç Hastalıkları)
Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.
Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.